The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome

被引:14
作者
Glaser, DA [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Dermatol, St Louis, MO 63104 USA
关键词
hyperhidrosis; botulinum toxin; Frey's syndrome;
D O I
10.1007/BF03033936
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Hyperhidrosis is a chronic condition characterized by excessive sweating. Recent studies report that it affects approximately 2.8% of the population and typically begins during adolescence. Gustatory sweating usually occurs after parotid gland injury or surgery, and both disorders can be debilitating for those who are affected. Both diseases respond very well to botulinum toxin therapy and this article will review the use of botulinum toxins, including the serotypes used, dosing, and complications.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 24 条
[1]
Systemic adverse effects after botulinum toxin type B (Myobloc) injections for the treatment of palmar hyperhidrosis [J].
Baumann, LS ;
Halem, ML .
ARCHIVES OF DERMATOLOGY, 2003, 139 (02) :226-227
[2]
Botulinum toxin A in the treatment of patients with Frey syndrome [J].
Beerens, AJF ;
Snow, GB .
BRITISH JOURNAL OF SURGERY, 2002, 89 (01) :116-119
[3]
Frey's syndrome: treatment with botulinum toxin [J].
Bjerkhoel, A ;
Trobbe, O .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1997, 111 (09) :839-844
[4]
Botulinum toxin - A possible new treatment for axillary hyperhidrosis [J].
Bushara, KO ;
Park, DM ;
Jones, JC ;
Schutta, HS .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1996, 21 (04) :276-278
[5]
Botulinum toxin type B for treatment of axillar hyperhidrosis [J].
Dressler, D ;
Saberi, FA ;
Benecke, R .
JOURNAL OF NEUROLOGY, 2002, 249 (12) :1729-1732
[6]
Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A [J].
Eckardt, A ;
Kuettner, C .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (08) :624-628
[7]
GLASER DA, 2006, IN PRESS HYPERHIDROS
[8]
GLASER DA, 2004, SUMM AM AC DERM M NE
[9]
GLASER DA, 2005, AM AC DERM ANN SUMM
[10]
Increased botulinum toxin type a dosage is more effective in patients with Frey's syndrome [J].
Guntinas-Lichius, O .
LARYNGOSCOPE, 2002, 112 (04) :746-749